USPTO Examiner KINGDON CATHY - Art Unit 1663

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18589678SOYBEAN VARIETY 5PEVE11February 2024February 2026Allow2410YesNo
18590070SOYBEAN VARIETY 5PPZM06February 2024February 2026Allow2410YesNo
18683746METHODS AND COMPOSITIONS FOR ENHANCED PROTEIN PRODUCTION IN BACILLUS CELLSFebruary 2024February 2026Allow2400YesNo
18414146SOYBEAN CULTIVAR 29020100January 2024February 2026Allow2510NoNo
18401384WHEAT CULTIVAR 01095198December 2023February 2026Allow2510NoNo
18397895PLANTS AND SEEDS OF CORN VARIETY CV850024December 2023January 2026Allow2510NoNo
18397432PLANTS AND SEEDS OF CORN VARIETY CV962284December 2023January 2026Allow2510NoNo
18397154PLANTS AND SEEDS OF CORN VARIETY CV960136December 2023January 2026Allow2510NoNo
18397116PLANTS AND SEEDS OF HYBRID CORN VARIETY CH010531December 2023January 2026Allow2410NoNo
18398100PLANTS AND SEEDS OF HYBRID CORN VARIETY CH010551December 2023January 2026Allow2410NoNo
18397301PLANTS AND SEEDS OF HYBRID CORN VARIETY CH010478December 2023January 2026Allow2410NoNo
18397225PLANTS AND SEEDS OF HYBRID CORN VARIETY CH010439December 2023January 2026Allow2410NoNo
18397840PLANTS AND SEEDS OF HYBRID CORN VARIETY CH010572December 2023January 2026Allow2410NoNo
18397329PLANTS AND SEEDS OF HYBRID CORN VARIETY CH010457December 2023January 2026Allow2410NoNo
18396589PLANTS AND SEEDS OF CORN VARIETY CV609093December 2023January 2026Allow2510NoNo
18396551PLANTS AND SEEDS OF HYBRID CORN VARIETY CH010533December 2023January 2026Allow2410NoNo
18395497PLANTS AND SEEDS OF HYBRID CORN VARIETY CH010450December 2023January 2026Allow2410NoNo
18393868PLANTS AND SEEDS OF CORN VARIETY CV993144December 2023January 2026Allow2510NoNo
18393863PLANTS AND SEEDS OF HYBRID CORN VARIETY CH010546December 2023January 2026Allow2510NoNo
18393824PLANTS AND SEEDS OF HYBRID CORN VARIETY CH010535December 2023January 2026Allow2510NoNo
18392929SOYBEAN CULTIVAR 24290269December 2023December 2025Allow2410NoNo
18389761PLANTS AND SEEDS OF CORN VARIETY CV957366December 2023December 2025Allow2410NoNo
18389744PLANTS AND SEEDS OF CORN VARIETY CV978472December 2023December 2025Allow2410NoNo
18544265PLANTS AND SEEDS OF CORN VARIETY CV576039December 2023December 2025Allow2410NoNo
18542695PLANTS AND SEEDS OF CORN VARIETY CV976070December 2023January 2026Allow2510NoNo
18541423PLANTS AND SEEDS OF HYBRID CORN VARIETY CH010555December 2023January 2026Allow2510NoNo
18536024PLANTS AND SEEDS OF HYBRID CORN VARIETY CH010517December 2023November 2025Allow2310NoNo
18535965PLANTS AND SEEDS OF HYBRID CORN VARIETY CH010508December 2023November 2025Allow2310NoNo
18535986PLANTS AND SEEDS OF HYBRID CORN VARIETY CH010524December 2023November 2025Allow2310NoNo
18535851PLANTS AND SEEDS OF HYBRID CORN VARIETY CH010513December 2023November 2025Allow2310NoNo
18534646PLANTS AND SEEDS OF CORN VARIETY CV990607December 2023December 2025Allow2410NoNo
18519122SOYBEAN VARIETY 01098104November 2023February 2026Allow2610NoNo
18519028SOYBEAN VARIETY 01098384November 2023February 2026Allow2610NoNo
18285048STAY GREEN CUCURBITACEAE PLANTSeptember 2023March 2026Allow2911YesNo
18370731SOYBEAN CULTIVAR 26460824September 2023December 2025Allow2710NoNo
18241150SOYBEAN CULTIVAR 21280671August 2023December 2025Allow2710NoNo
18304467MAIZE HYBRID X14T116April 2023December 2025Allow3210NoNo
18157187PLANT TRANSACTIVATION INTERACTION MOTIFS AND USES THEREOFJanuary 2023February 2026Allow3720NoNo
18083610SOYBEAN LINE EC2020472December 2022January 2026Allow3721NoNo
18072010SOYBEAN VARIETY '20270943'November 2022February 2026Allow3811NoNo
17692479Canola Hybrid Variety 9CN0099March 2022September 2024Abandon3021NoNo
17692631Canola Hybrid Variety 9CN0089March 2022September 2024Abandon3021NoNo
17644007SORGHUM HYBRID XSW7611December 2021December 2025Allow4840NoNo
17617635A SEEDLESS BLACK RASPBERRY WITH A MUTANT AGAMOUS-CLADE MADS-BOX TRANSCRIPTION FACTOR GENEDecember 2021February 2026Allow5031NoNo
16290573Method, Vectors, Cells, Seeds and Kits for Stacking Genes into a Single Genomic SiteMarch 2019March 2021Allow2411NoNo
16126124GENETICALLY ALTERED GUAYULE HAVING INCREASED RUBBER PRODUCTION AND METHODS THEREOFSeptember 2018November 2020Allow2621YesNo
15579690MATERIALS AND METHODS FOR PRODUCING ENDOSTATIN FUSION POLYPEPTIDES IN PLANT CELLSDecember 2017July 2020Allow3231NoNo
15153984POTATO CULTIVAR V11May 2016January 2018Allow2010NoNo
15050846SOYBEAN CULTIVAR BY1213086February 2016December 2016Allow1000YesNo
14889254MODIFIED EXPRESSION OF PROLYL-4-HYDROXYLASE IN PHYSCOMITRELLA PATENSNovember 2015August 2018Allow3411YesNo
14932326SYNTHESIS OF SIALIC ACID IN PLANTSNovember 2015January 2017Allow1400YesNo
14224592SOYBEAN CULTIVAR BY1212201March 2014September 2015Allow1800YesNo
14224748SOYBEAN CULTIVAR WN1118297March 2014September 2015Allow1700YesNo
13921737GNTIII EXPRESSION IN PLANTSJune 2013September 2015Allow2700YesNo
13861951CHIMERIC PROMOTERS COMPRISING A RICE ACTIN 1 PROMOTER AND 35S ENHANCERS FOR USE IN PLANTSApril 2013May 2016Allow3721YesNo
13845166SOYBEAN CULTIVAR WN1013689-2March 2013April 2015Allow2500YesNo
13793475SOYBEAN CULTIVAR SJ1012347March 2013December 2014Allow2100YesNo
13793737SOYBEAN CULTIVAR SJ1012389March 2013December 2014Allow2100YesNo
13458083TRANSGENIC PLANTS EXPRESSING GALACTOSYLTRANSFERASE AND SIALYL TRANSFERASEApril 2012July 2014Allow2720YesNo
13254704IMMUNOASSAY FOR DETECTING THYROGLOBULIN UTILIZING SOYBEAN PRODUCED RECOMBINANT THYROGLOBULINSeptember 2011August 2016Allow6031YesNo
12278677Synthesis of Sialic Acid in PlantsAugust 2009August 2015Allow6051YesNo
10595610PHARMACEUTICAL PRODUCT COMPRISING TRANSGENIC POLLEN EXPRESSING HETEROLOGOUS POLYPEPTIDESJanuary 2008September 2015Allow6051YesNo
10590490AN ARABIDOPSIS-STOMATAL-SPECIFIC PROMOTER AND A GENETIC CONSTRUCT CONTAINING THE PROMOTER FOR EXPRESSION OF NUCLEIC ACIDS IN PLANTSJune 2007October 2009Allow3831NoNo
10558220BIOREACTOR CONTAINING CELLS EXPRESSING GLYCOSYLTRANSFERASE NUCLEIC ACIDS ISOLATABLE FROM ARABIDOPSISDecember 2006September 2009Allow4621NoNo
11585040PREPARATION OF VACCINE MASTER CELL LINES USING RECOMBINANT PLANT SUSPENSION CULTURESOctober 2006March 2009Allow2921NoNo
10539992A NUCLEIC ACID FOR REDUCING PROTEIN CONTENT IN RICE SEEDApril 2006February 2010Allow5611NoNo
11067425REGULATION OF GENE EXPRESSION USING CHROMATIN REMODELLING FACTORSFebruary 2005February 2009Allow4821NoNo
10486376REGULATION OF PEROXISOMAL FATTY ACID TRANSPORT IN PLANTSJuly 2004August 2009Allow6041YesNo
10861910CELLULOSE SYNTHASE FROM PINE AND METHODS OF USEJune 2004October 2009Allow6030YesYes
10434968INCREASING HOST PLANT SUSCEPTIBILITY TO AGROBACTERIUM INFECTION BY OVEREXPRESSION OF THE ARABIDOPSIS VIP1 GENEMay 2003September 2009Allow6032YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner KINGDON, CATHY.

Strategic Value of Filing an Appeal

Total Appeal Filings
1
Allowed After Appeal Filing
0
(0.0%)
Not Allowed After Appeal Filing
1
(100.0%)
Filing Benefit Percentile
0.9%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner KINGDON, CATHY - Prosecution Strategy Guide

Executive Summary

Examiner KINGDON, CATHY works in Art Unit 1663 and has examined 28 patent applications in our dataset. With an allowance rate of 100.0%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 34 months.

Allowance Patterns

Examiner KINGDON, CATHY's allowance rate of 100.0% places them in the 94% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by KINGDON, CATHY receive 1.86 office actions before reaching final disposition. This places the examiner in the 44% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by KINGDON, CATHY is 34 months. This places the examiner in the 42% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +0.0% benefit to allowance rate for applications examined by KINGDON, CATHY. This interview benefit is in the 12% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 37.5% of applications are subsequently allowed. This success rate is in the 85% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 33.3% of cases where such amendments are filed. This entry rate is in the 49% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 87% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 25.0% are granted (fully or in part). This grant rate is in the 13% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 17.9% of allowed cases (in the 97% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 3% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.